Kinnate Biopharma Stock Price, News & Analysis

KNTE NASDAQ

Company Description

Kinnate Biopharma (NASDAQ: KNTE) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

KNTE stock has declined 100.0% over the past year.

This page provides a comprehensive overview of KNTE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

47.2M

Shares outstanding

Kinnate Biopharma (KNTE) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

March 1, 2024

+4.86%

Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories

February 16, 2024

+12.33%

Kinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per Share

acquisition

November 9, 2023

+2.50%

Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

earnings

September 18, 2023

-11.76%

Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring

August 8, 2023

+0.76%

Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates

earnings

June 1, 2023

-1.40%

Kinnate Biopharma Inc. to Participate in Upcoming Investor Conferences

conferences

Kinnate Biopharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences. View all KNTE news →

SEC Filings

View All

No SEC filings available for KNTE.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

KNTE Company Profile & Sector Positioning

Kinnate Biopharma (KNTE) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.